Samelia Growth Partners is a boutique advisory firm helping healthcare and life sciences leaders design and execute growth strategies across Latin America’s complex markets.
Samelia Growth Partners helps healthcare, life sciences, and growth-oriented organizations accelerate revenue, strengthen market positioning, and execute high-impact commercial strategies across Latin America.
Executive-level strategic and commercial advisory for healthcare and life sciences.
We work with organizations that shape healthcare and life sciences across Latin America.
Pharmaceutical Companies
Strategic growth, market access, and commercial execution in complex therapeutic areas.
Biotechnology Companies
Scaling innovative therapies with clear market entry, access, and commercialization strategies.
MedTech & Diagnostics Companies
Bringing technologies to market with tailored go-to-market, adoption, and access strategies.
Healthcare Organizations
Providers, networks, and healthcare platforms seeking sustainable growth and operational excellence.
Public-Sector & Institutional Stakeholders
Advisory on healthcare programs, partnerships, and public–private collaboration models.
- We also work with investors and investment-backed companies where the mandate is clearly strategic advisory rather than investment management.
WHAT WE DELIVER
Strategic advisory that connects growth ambition with executable plans.
Strategic Advisory
- Problem
Leadership teams need clarity on where to focus, how to grow, and how to align stakeholders in complex healthcare and life sciences markets.
Strategic intervention
We work with executives to define strategic priorities, portfolio and market choices, and integrated growth strategies that connect market access, medical, regulatory, and commercial perspectives.
Business outcome
Clear direction, aligned leadership, and a roadmap that links strategy to commercial and organizational execution.
Commercial & Market Access
- Problem
Organizations need to accelerate growth while navigating complex access, pricing, and reimbursement environments.
Strategic intervention
We design market access strategies, stakeholder engagement plans, and access programs that are coordinated with commercial objectives and local healthcare system realities.
Business outcome
Stronger access foundations, better alignment with payers and institutions, and more predictable, sustainable commercial performance.
Commercial Excellence
- Problem
Even strong strategies underperform without the right commercial model, capabilities, and execution discipline.
Strategic intervention
We support go-to-market design, account and segment strategies, sales force effectiveness, and performance management tailored to healthcare and life sciences.
Business outcome
Sharper commercial focus, improved field execution, and better use of resources across markets and channels.
Commercial & Market Access
Problem
Healthcare and life sciences companies need to accelerate growth while navigating complex access, pricing, and reimbursement environments across Latin America.
Strategic intervention
We design market access and commercial strategies that integrate payer, institutional, and channel perspectives, ensuring that access decisions and commercial plans reinforce each other.
Business outcome
Stronger access foundations, better alignment with payers and institutions, and more predictable, sustainable commercial performance.
Samelia Growth Partners supports healthcare and life sciences organizations in connecting market access with commercial strategy, so that growth plans are realistic, compliant, and executable in each market.
What we deliver
Market access strategy
Institutional and stakeholder engagement
Pricing and reimbursement strategy
Access programs and patient support models
Our approach connects market access with commercial execution, ensuring that strategic decisions on access, pricing, and reimbursement translate into measurable business results.
Medical & Regulatory Strategy
Problem
Medical and regulatory decisions can accelerate or constrain growth if they are not integrated with broader strategy.
Strategic intervention
We help organizations define medical and regulatory strategies, evidence and data needs, and cross-functional ways of working that support access and commercial objectives.
Business outcome
Stronger alignment between medical, regulatory, market access, and commercial teams, with strategies that are compliant, credible, and executable.
Strategic Advisory Capabilities
- Strategic capabilities
Medical and regulatory strategy
Product launch readiness
Evidence and data strategy
Cross-functional governance and ways of working
Our approach ensures that medical and regulatory considerations are built into strategic and commercial decisions from the outset, rather than treated as downstream constraints.
Samelia Growth Partners brings experience in environments where scientific, regulatory, and commercial priorities must be balanced carefully to achieve sustainable growth.
IP & Compliance
Problem
Intellectual property and compliance requirements can create uncertainty in how to grow, innovate, and communicate in healthcare and life sciences.
Strategic intervention
We advise on IP and compliance considerations within broader growth and commercialization strategies, helping leadership teams make informed decisions about risk, protection, and market activity.
Business outcome
Clearer decision-making on how to protect strategic assets, manage risk, and pursue growth in ways that respect regulatory and compliance boundaries.
What we deliver
Strategic capabilities
Intellectual property and asset protection considerations within growth strategies
Compliance-sensitive go-to-market and communication approaches
Risk and governance considerations for strategic initiatives
Our approach connects IP and compliance decisions with strategic and commercial choices, so that growth plans are both ambitious and responsible.
Latin America Focus
Latin America offers significant growth potential in healthcare and life sciences, but each market operates with its own regulatory, institutional, and commercial realities. Samelia helps clients navigate this complexity with strategies that are both ambitious and executable.
We understand how to operate across Latin American healthcare markets, including:
• Market access pathways and reimbursement dynamics
• Public and private healthcare systems
• Regulatory and medical requirements
• Institutional and stakeholder landscapes
• Commercial and channel dynamics
• Local market execution and cross-functional coordination
Our work is tailored to each client and market. We bring regional expertise and a structured approach to market-specific engagements.
Our Approach
From strategic diagnosis to measurable commercial execution.
DIAGNOSE
Understand the market, stakeholders, performance, and constraints. Identify growth opportunities, risks, and strategic options.
DESIGN
Define clear strategic choices, market access and commercial strategies, and cross-functional plans aligned with leadership priorities.
EXECUTE
Translate strategy into concrete initiatives, governance, and ways of working. Support teams in moving from plans to action.
SCALE
Extend successful models across markets, segments, or portfolios while adapting to local realities.
MEASURE
Track impact with relevant commercial, access, and strategic indicators. Refine and adjust based on evidence and feedback.
We do not stop at strategy decks. We help clients move from insight to execution and measurable results.